Profile change history

What changed for Rusfertide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Rusfertide identity.

11Total events
11Record additions
0Version changes
3Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 11 connected records →

Showing the latest 11 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT04202965

PeptideScanner retained ClinicalTrials.gov record NCT04202965 at 2026-11-16T01:38:51.796Z. Its registry update date was 2025-08-20, and PeptideScanner's reviewed identity mapping was rusfertide.

PeptideScanner change date
November 16, 2026
Cited source date
August 20, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04767802

PeptideScanner retained ClinicalTrials.gov record NCT04767802 at 2026-11-16T01:38:51.796Z. Its registry update date was 2024-03-18, and PeptideScanner's reviewed identity mapping was rusfertide.

PeptideScanner change date
November 16, 2026
Cited source date
March 18, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05210790

PeptideScanner retained ClinicalTrials.gov record NCT05210790 at 2026-11-16T01:38:51.796Z. Its registry update date was 2026-10-19, and PeptideScanner's reviewed identity mapping was rusfertide.

PeptideScanner change date
November 16, 2026
Cited source date
October 19, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07648030

PeptideScanner retained ClinicalTrials.gov record NCT07648030 at 2026-11-16T01:38:51.796Z. Its registry update date was 2026-10-02, and PeptideScanner's reviewed identity mapping was rusfertide.

PeptideScanner change date
November 16, 2026
Cited source date
October 2, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07765602

PeptideScanner retained ClinicalTrials.gov record NCT07765602 at 2026-11-16T01:38:51.796Z. Its registry update date was 2026-08-28, and PeptideScanner's reviewed identity mapping was rusfertide.

PeptideScanner change date
November 16, 2026
Cited source date
August 28, 2026
Evidence lane
Clinical trials
Record added

Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.

PubMed lists PMID 37863080 in The lancet. Gastroenterology & hepatology as Clinical Trial, Phase II, Multicenter Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-10-17 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 5, 2025
Evidence lane
Literature metadata
Record added

Rusfertide for iron overload in haemochromatosis - Authors' reply.

PubMed lists PMID 38340748 in The lancet. Gastroenterology & hepatology as Letter, Comment, with publication-date metadata of 2024-03 (month precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 5, 2025
Evidence lane
Literature metadata
Record added

Rusfertide for iron overload in haemochromatosis.

PubMed lists PMID 38340749 in The lancet. Gastroenterology & hepatology as Letter, Comment, with publication-date metadata of 2024-03 (month precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 5, 2025
Evidence lane
Literature metadata
Record added

VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy.

PubMed lists PMID 42868322 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Journal Article, with publication-date metadata of 2026-10-13 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 13, 2026
Evidence lane
Literature metadata
Record added

Rusfertide for the treatment of polycythemia vera.

PubMed lists PMID 42958870 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2026-10-31 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 31, 2026
Evidence lane
Literature metadata